We are live on
!
Find out more
NCM
Nantahala Capital Management Portfolio holdings
AUM
$2.72B
1-Year Est. Return
121.58%
This Fund
S&P 500
This Quarter
Est. Return
+42.28%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$3.23B
AUM Growth
-$42M
(-1.3%)
Cap. Flow
-$623M
Cap. Flow
% of AUM
-19.3%
Top 10 Holdings %
Top 10 Hldgs %
49.44%
Holding
136
New
22
Increased
36
Reduced
40
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARS Pharmaceuticals
SPRY
|
+$40.3M |
| 2 |
SFT
Shift Technologies, Inc. Class A Common Stock
SFT
|
+$23.7M |
| 3 |
MILE
Metromile, Inc. Common Stock
MILE
|
+$22.8M |
| 4 |
IMAX
IMAX
|
+$22.3M |
| 5 |
Keros Therapeutics
KROS
|
+$16.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
World Acceptance Corp
WRLD
|
+$22.4M |
| 2 |
Marriott Vacations Worldwide
VAC
|
+$16.8M |
| 3 |
INAQU
INSU Acquisition Corp. II Unit
INAQU
|
+$16.3M |
| 4 |
FRG
Franchise Group, Inc.
FRG
|
+$15.2M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$15.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.66% |
| 2 | Consumer Discretionary | 8.76% |
| 3 | Industrials | 6.02% |
| 4 | Financials | 5.59% |
| 5 | Technology | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SLNO
51
DELISTED
Soleno Therapeutics
SLNO
| $15.2M | 0.47% |
524,757
+29,666
| +6% | +$856K |
|
|
PAYA
52
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $14.8M | 0.46% |
1,100,000
+1,077,022
| +4,687% | +$12.5M |
|
|
FTIVU
53
DELISTED
FinTech Acquisition Corp. IV Unit
FTIVU
| $14.3M | 0.44% |
1,200,000
-750,000
| -38% | -$7.86M |
|
|
SIC
54
DELISTED
Select Interior Concepts, Inc. Class A Common Stock
SIC
| $13.6M | 0.42% |
1,901,943
-155,265
| -8% | -$1.12M |
|
|
ZVO
55
DELISTED
Zovio Inc. Common Stock
ZVO
| $13.5M | 0.42% |
2,841,286
-11,801
| -0.4% | -$48.5K |
|
56
Curis
CRIS
$4.58M
| $13.4M | 0.41% |
+4,082
| New | +$4.9M |
|
57
PAR Technology
PAR
$729M
| $12.7M | 0.39% |
202,312
-154,325
| -43% | -$7.58M |
|
58
Children's Place
PLCE
$58.9M
| $12.6M | 0.39% |
+252,472
| New | +$9.19M |
|
59
Gyre Therapeutics
GYRE
$706M
| $11.8M | 0.36% |
248,711
+5,811
| +2% | +$252K |
|
|
CERE
60
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $11.4M | 0.35% |
+685,704
| New | +$8.91M |
|
|
STR
61
DELISTED
Sitio Royalties
STR
| $11.1M | 0.35% |
884,427
+57,388
| +7% | +$582K |
|
|
FTOCU
62
DELISTED
FTAC Olympus Acquisition Corp. Unit
FTOCU
| $10.9M | 0.34% |
1,000,000
| – | – |
|
63
DHI Group
DHX
$160M
| $10.7M | 0.33% |
4,837,713
-1,882
| -0% | -$3.86K |
|
|
FTCVU
64
DELISTED
FinTech Acquisition Corp. V Unit
FTCVU
| $10.7M | 0.33% |
+1,000,000
| New | +$10.4M |
|
|
IIIIU
65
DELISTED
INSU Acquisition Corp. III Unit
IIIIU
| $10.6M | 0.33% |
+1,000,000
| New | +$10.6M |
|
66
Yatra Online
YTRA
$51.9M
| $10.3M | 0.32% |
5,315,350
-4,650
| -0.1% | -$6.48K |
|
|
ZGNX
67
DELISTED
Zogenix, Inc.
ZGNX
| $10.2M | 0.32% |
+511,857
| New | +$10.5M |
|
68
Lincoln Educational Services
LINC
$975M
| $10.1M | 0.31% |
1,555,022
-305,170
| -16% | -$1.81M |
|
|
BMY.RT
69
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $10.1M | 0.31% |
14,602,975
-834,361
| -5% | -$1.78M |
|
70
Reading International Class A
RDI
$34.5M
| $9.96M | 0.31% |
1,983,928
+83,110
| +4% | +$290K |
|
|
LNW
71
DELISTED
Light & Wonder
LNW
| $9.84M | 0.31% |
237,260
-50,542
| -18% | -$1.86M |
|
72
The RMR Group
RMR
$337M
| $9.54M | 0.3% |
+246,994
| New | +$8.12M |
|
73
Rafael Holdings
RFL
$101M
| $9.08M | 0.28% |
394,821
-65,165
| -14% | -$1.28M |
|
74
Nature's Sunshine
NATR
$289M
| $8.98M | 0.28% |
600,409
+3,099
| +0.5% | +$38.3K |
|
75
DarioHealth
DRIO
$75.3M
| $8.49M | 0.26% |
29,711
| – | – |
|
Similar funds
TAM
XL
NB
PA
BCM
SCM
HCM
GC
Nantahala Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Nantahala Capital Management held 136 positions worth $3.23B, down 1.3% from $3.27B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Nantahala Capital Management withdrew a net $623M in Q4 2020, closing 23 positions and reducing 40 holdings. Its most notable exit was World Acceptance Corp, an estimated $22.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Nantahala Capital Management opened a new position in ARS Pharmaceuticals worth $54.4M.
- Nantahala Capital Management's largest Q4 2020 buy was ARS Pharmaceuticals: 1,206,471 shares worth $54.4M.
- Nantahala Capital Management added most to Shift Technologies, Inc. Class A Common Stock in Q4 2020, an estimated $23.7M increase.
- Nantahala Capital Management's biggest Q4 2020 reduction was Marriott Vacations Worldwide, cutting an estimated $16.8M.
- Nantahala Capital Management fully exited World Acceptance Corp in Q4 2020, selling an estimated $22.4M.
- Nantahala Capital Management's ten largest holdings make up 49% of its $3.23B portfolio in Q4 2020.
- Nantahala Capital Management opened 22 new positions and closed 23 in Q4 2020.
- Nantahala Capital Management's portfolio value fell 1.3% quarter-over-quarter to $3.23B.
Based on Nantahala Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.